#United States #Florida Cancer Specialists #Fort Myers #Oncology Care #U.S. Veterans

Florida Cancer Specialists Innovate to Enhance Cancer Care for Veterans

Florida Cancer Specialists & Research Institute, LLC (FCS) has announced significant advancements in their efforts to improve cancer care for U.S. veterans, demonstrating a strong commitment to addressing the unique healthcare needs of this demographic. With the rising number of veterans diagnosed with cancer, estimated at 56,000 annually, FCS aims to ensure that these individuals have access to innovative, high-quality oncology services.

Key Initiatives for Veteran Care

FCS President and Managing Physician, Dr. Lucio N. Gordan, will highlight these advancements at the 7th Annual Conquering Cancer, Together event, part of the ASCO® 2026 Annual Meeting. The organization’s CEO, Ryan Ciarrocchi, stated that the mission to care for veterans is central to their operations. FCS is the largest community-based oncology provider in Florida, tailored to deliver comprehensive and timely care shaped by the complexities of military service.

FCS has implemented several initiatives to facilitate veterans’ access to care:
1. Rapid Appointments: Designed to offer appointments within 72 hours of diagnosis, FCS works closely with the Veterans Affairs (VA) system, mitigating administrative hurdles to expedite care continuity.
2. Telehealth Services: As part of the VA National TeleOncology Program, FCS leverages technology to provide virtual consultations, making it especially beneficial for veterans in rural areas who may face travel challenges to receive specialized care.
3. Personalized Treatment Approaches: By utilizing advanced molecular profiling and next-generation sequencing, physicians at FCS can customize treatment plans that account for each veteran’s specific cancer characteristics.

Supporting Long-Term Care

Veterans often deal with complex health challenges throughout their cancer journey. FCS emphasizes the importance of ongoing support and personalized treatment. Their patient navigators are trained to understand military culture, providing insights into how service impacts health, hence improving trust and communication between patients and providers.

Kiana Mehring, VP of payer strategy and revenue cycle management at FCS, notes that these programs are vital in enhancing patient experiences and outcomes. Furthermore, FCS invests in real-world data analysis to identify treatment gaps and optimize care pathways efficiently.

Expanding Clinical Research Opportunities

FCS is also enhancing participation in clinical trials, which are crucial for advancing cancer treatments. The institute offers an extensive portfolio of more than 180 clinical trials covering prevalent veteran cancers such as prostate, lung, and breast cancers. A $1 million grant from the Florida Cancer Innovation Fund underpins their Research Patient Navigator Program aimed at raising clinical trial awareness, particularly in underserved communities.

Dr. Gordan stressed that access to clinical research is key to improving treatment outcomes. This initiative not only aims to bring innovative therapies closer to veterans but also seeks to pave the way for health equity in oncology.

Meeting a Growing Need

The initiatives rolled out by FCS respond directly to the increasing rates of cancer among veterans, reported to be 20-40% higher than the general population. By combining quick access, personalized care, and clinical research, FCS sets a new standard for community oncology that caters specifically to veterans’ healthcare needs.

Ciarrocchi expressed pride in the dedicated teams behind these initiatives. Their unwavering commitment aims to guarantee that veterans receive the top-tier cancer care they’ve earned. As FCS continues to lead in oncology innovations, their focus remains on developing scalable models that can be implemented for improved community healthcare access in the future.

About Florida Cancer Specialists & Research Institute, LLC

With a legacy spanning over 40 years, FCS has integrated advanced technologies and innovative practices into cancer care, becoming a leader in clinical research among private oncology practices both in Florida and nationwide. The institute conducts over 180 active clinical trials annually, providing patients with access to cutting-edge therapies that often become standard care post-FDA approval.